OSSC LTR Prelims Result 2024 declared for TGT Arts. The results can be checked on the official website of OSSC at ossc.gov.in. Odisha Staff Selection Commission declared OSSC LTR Prelims Result ...

OSSC LTR Result 2025: The Odisha Staff Selection Commission (OSSC) has officially announced the OSSC LTR Result 2025 for the Preliminary Examination. Candidates who appeared in the Leave Training ...

OSSC LTR Result 2025: The OSSC LTR Result 2025 for the preliminary exam held on March 23, 2025, has been made public by the Odisha Staff Selection Commission (OSSC). On the official website ...

The Odisha Staff Selection Commission (OSSC) has released the OSSC LTR Result 2025 for the Preliminary Examination conducted on March 23, 2025. Candidates who appeared for the Leave Training ...

The Odisha Staff Selection Commission (OSSC) has declared the Preliminary exam result for the TGT Arts posts under Leave Training Reserve (LTR) Teachers 2024 (Advt no-4231/OSSC dtd 22.10.2024).

Ilion mayor John Stephens says with the loss of revenue from the Remington plant, this was not an easy budget to achieve. He credited department heads with thinking outside the box. Using grants, and ...

“In her initial round of visits, Minister Lightbourne met with the leadership and staff of the Department of Land Title Registry [LTR] and Consumer Affairs. “With Consumer Affairs, Minister ...

This information will be updated as needed. Stories by Kaylee Remington MTV hit show to honor iconic actress during season finale Nintendo unveils new Switch; When can you buy it? Convenience ...

The Odisha Staff Selection Commission (OSSC) is set to close the objection window for the LTR Teacher Recruitment Prelims Exam 2024 answer key today, i.e., March 27. Candidates who appeared for the ...

The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the US market. As with LTR’s foundation product Spontan, Roxus is based on the ...

It’s up and go time for LTR in the US market All the budget healthcare news – and it’s a short item Prescient launches phase 2a study for a rare blood cancer The developer of a nasal spray-mist ...